Skip to main content
. 2021 Jun 7:1–8. doi: 10.1017/dmp.2021.169

Table 4.

Comparison of knowledge about COVID-19 among medical students in relation to academic grade

Items of knowledge of COVID-19 Preclinical (N = 194) Clinical (N = 245) X 2 P-Value
n % n %
Main clinical symptom
 Fever 177 91.2 237 96.7 6.093 0.014*
 Fatigue 150 77.3 194 79.2 0.222 0.638
 Dry cough 184 94.8 235 95.9 0.287 0.592
 Dyspnea 148 76.3 189 77.1 0.044 0.833
 Myalgia 68 35.1 100 40.8 1.523 0.217
Unlike common cold, stuffy nose, runny nose, and sneezing are less common 133 68.6 185 75.5 2.622 0.105
Currently, there is no effective cure 165 85.1 208 84.9 0.002 0.964
Early symptomatic and supportive treatment can help most patients recover from the infection 174 89.7 209 85.3 1.870 0.171
Low-risk groups for infection
 Children 103 53.1 138 56.3 0.457 0.499
 Adults 154 79.4 197 80.4 0.071 0.790
High-risk groups for infection
 Pregnant females 114 58.8 163 66.5 2.806 0.094
 Elderly people 181 93.3 232 94.7 0.378 0.539
 Obese patients 79 40.7 101 41.2 0.011 0.915
 Chronic patients 170 87.6 219 89.4 0.332 0.565
Eating or contacting wild animals would not result in infection 91 46.9 116 47.3 0.008 0.927
Infected persons can transmit the virus to others when fever is not present 168 86.6 200 81.6 1.696 0.161
COVID-19 virus spreads via respiratory droplets of infected individuals 193 99.5 240 98.0 FE 0.235
People can wear general medical masks to prevent infection 123 63.4 174 71.0 2.872 0.090
It is necessary for children and young adults to take measures to prevent infection 165 85.1 222 90.6 3.206 0.073
To prevent infection individuals should avoid going to crowded places and avoid taking public transportations 190 97.9 238 97.1 FE 0.762
Isolation and treatment of people who are infected are effective to reduce spread of the virus 185 95.4 233 95.1 0.016 0.900
People who have contact with someone infected virus should be immediately isolated in a proper place 184 94.8 224 91.4 1.926 0.165
The observation period for people who have contact with patients should be 7-14 days 116 59.8 137 55.9 0.666 0.414
The virus mainly affects lungs, and can cause permanent lung damage 167 86.1 211 86.1 0.001 0.990
The virus can live on surfaces for a long period of time 119 61.3 148 60.4 0.039 0.843
The virus can be transmitted in a hot climate 102 52.6 136 55.5 0.375 0.540
Diagnosis can be confirmed by PCR 167 86.1 213 86.9 0.068 0.794
The flu vaccine cannot protect against COVID-19 virus 123 63.4 179 73.1 4.705 0.030*
The incubation period of COVID-19 virus is 2-14 days 160 82.5 203 82.9 0.011 0.916
Older people who suffer from chronic medical conditions are more vulnerable to becoming ill with COVID-19 virus 173 89.2 224 91.4 0.635 0.425
Plasma of cured COVID-19 patients can be effective in treatment of infection 104 53.6 128 52.2 0.081 0.776
Most common ethnic group at high risk of mortality if infected are black persons 16 8.2 20 8.2 0.001 0.975
*

P < 0.05